Expert Perspectives on the Evolving Ovarian Cancer Clinical Landscape
With a growing number of clinical trials in ovarian cancer, healthcare providers must make sense of rapidly accumulating data to inform decisions about treatment choice. In this video series, experts in gynecologic oncology provide important insights into interpreting clinical trial data and highlight key considerations for the treatment of ovarian cancer.
To learn more, check out the Expert Perspectives Video Series using the links below.
Important Considerations for Interpreting Efficacy in Clinical Trials
Dr. Leslie Randall discusses the role of hazard ratios in understanding efficacy across clinical trials and reviews considerations for interpreting data from trials with different patient populations.
Role of Bevacizumab in Ovarian Cancer
Dr. Michael Birrer provides an overview of the role of bevacizumab in the treatment of patients with ovarian cancer.
Maintenance Therapy: An Essential Part of the Treatment Plan
Dr. Michael Birrer underscores the importance of making decisions about maintenance therapy at the beginning of ovarian cancer treatment.
Biomarkers in Ovarian Cancer
Dr. Thomas Herzog examines the role of biomarkers in the prognosis and treatment of ovarian cancer.